US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist
  • 2.420
  • +0.010+0.41%
Close Nov 21 16:00 ET
  • 2.480
  • +0.060+2.48%
Post 19:59 ET
2.93MMarket Cap-564P/E (TTM)

Lipella Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.26%-653.1K
-40.15%-918.14K
-28.86%-1.39M
-72.03%-3.15M
-214.27%-727.71K
-115.28%-689.36K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
Net income from continuing operations
-9.15%-1.44M
39.03%-938.15K
-11.61%-1.19M
-77.81%-4.62M
-89.29%-688.88K
-85.43%-1.32M
-96.76%-1.54M
-44.70%-1.07M
-39.25%-2.6M
5.40%-363.93K
Depreciation and amortization
-24.95%722
--1.37K
--72
--1.69K
--723
--962
--0
--0
--0
--0
Other non cash items
---3
---649
3,619.86%200.65K
1,160.92%121.2K
--0
----
----
233.37%5.39K
40.65%9.61K
174.29%4.7K
Change In working capital
92.88%411.39K
-250.01%-62.03K
-170.29%-605.99K
-195.64%-9.11K
-130.98%-39.55K
128.93%213.29K
416.57%41.35K
-13.09%-224.2K
-95.18%9.52K
509.76%127.66K
-Change in prepaid assets
851.32%163.84K
-114.76%-22.13K
-488.96%-733.6K
197.97%460.63K
243.76%104.82K
113.01%17.22K
201.78%149.98K
185.35%188.61K
-571.10%-470.18K
142.31%30.49K
-Change in payables and accrued expense
9.08%243.73K
55.30%-73.54K
137.08%164.04K
-192.59%-548.86K
-178.41%-165.33K
-0.92%223.44K
-222.66%-164.52K
-2,082.16%-442.46K
201.30%592.82K
419.24%210.86K
-Change in other current assets
81.37%-425
215.15%38
729.41%214
-518.03%-2.25K
391.18%99
-22,710.00%-2.28K
-118.44%-33
-108.44%-34
-71.43%538
-111.22%-34
-Change in other working capital
116.95%4.25K
-39.91%33.6K
-223.44%-36.65K
171.59%81.37K
--20.85K
---25.1K
--55.92K
--29.69K
-264.63%-113.66K
----
Cash from discontinued investing activities
Operating cash flow
5.26%-653.1K
-40.25%-918.79K
-28.80%-1.39M
-72.03%-3.15M
-214.27%-727.71K
-115.28%-689.36K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
Investing cash flow
Cash flow from continuing investing activities
-104.80%-14.43K
0
200.00%300.55K
0
Net PPE purchase and sale
----
----
----
---14.43K
--0
----
----
----
--0
----
Net investment purchase and sale
----
----
----
--0
----
----
----
----
200.00%300.55K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
-104.80%-14.43K
--0
----
----
----
200.00%300.55K
--0
Financing cash flow
Cash flow from continuing financing activities
820.33K
0
900.00%200K
-74.49%1.34M
-69.24%1.61M
0
-250K
-25K
149.82%5.24M
233,138.20%5.24M
Net issuance payments of debt
--0
--0
--0
-200.00%-275K
--0
--0
---250K
---25K
--275K
--275K
Net common stock issuance
--820.33K
--0
--200K
--0
--0
--0
--0
--0
136.71%4.96M
----
Proceeds from stock option exercised by employees
----
----
----
--1.61M
----
----
----
----
--0
----
Cash from discontinued financing activities
Financing cash flow
--820.33K
--0
900.00%200K
-74.49%1.34M
-69.24%1.61M
--0
---250K
---25K
149.82%5.24M
233,138.20%5.24M
Net cash flow
Beginning cash position
-61.89%1.19M
-47.61%2.11M
-35.69%3.29M
262.26%5.12M
1,999.68%2.41M
615.81%3.11M
869.77%4.02M
262.26%5.12M
133.02%1.41M
-94.74%114.77K
Current changes in cash
123.76%167.23K
-1.51%-918.79K
-7.75%-1.19M
-149.30%-1.83M
-82.35%883.89K
-119.79%-703.8K
-4,497.79%-905.11K
-10.36%-1.1M
359.42%3.71M
750.70%5.01M
End cash Position
-43.82%1.35M
-61.89%1.19M
-47.61%2.11M
-35.69%3.29M
-35.69%3.29M
1,999.68%2.41M
615.81%3.11M
869.77%4.02M
262.26%5.12M
262.26%5.12M
Free cash flow
7.20%-653.1K
-40.25%-918.79K
-28.80%-1.39M
-72.82%-3.16M
-214.27%-727.71K
-119.79%-703.8K
-12.96%-655.11K
-54.12%-1.08M
-85.10%-1.83M
50.85%-231.56K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.26%-653.1K-40.15%-918.14K-28.86%-1.39M-72.03%-3.15M-214.27%-727.71K-115.28%-689.36K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K
Net income from continuing operations -9.15%-1.44M39.03%-938.15K-11.61%-1.19M-77.81%-4.62M-89.29%-688.88K-85.43%-1.32M-96.76%-1.54M-44.70%-1.07M-39.25%-2.6M5.40%-363.93K
Depreciation and amortization -24.95%722--1.37K--72--1.69K--723--962--0--0--0--0
Other non cash items ---3---6493,619.86%200.65K1,160.92%121.2K--0--------233.37%5.39K40.65%9.61K174.29%4.7K
Change In working capital 92.88%411.39K-250.01%-62.03K-170.29%-605.99K-195.64%-9.11K-130.98%-39.55K128.93%213.29K416.57%41.35K-13.09%-224.2K-95.18%9.52K509.76%127.66K
-Change in prepaid assets 851.32%163.84K-114.76%-22.13K-488.96%-733.6K197.97%460.63K243.76%104.82K113.01%17.22K201.78%149.98K185.35%188.61K-571.10%-470.18K142.31%30.49K
-Change in payables and accrued expense 9.08%243.73K55.30%-73.54K137.08%164.04K-192.59%-548.86K-178.41%-165.33K-0.92%223.44K-222.66%-164.52K-2,082.16%-442.46K201.30%592.82K419.24%210.86K
-Change in other current assets 81.37%-425215.15%38729.41%214-518.03%-2.25K391.18%99-22,710.00%-2.28K-118.44%-33-108.44%-34-71.43%538-111.22%-34
-Change in other working capital 116.95%4.25K-39.91%33.6K-223.44%-36.65K171.59%81.37K--20.85K---25.1K--55.92K--29.69K-264.63%-113.66K----
Cash from discontinued investing activities
Operating cash flow 5.26%-653.1K-40.25%-918.79K-28.80%-1.39M-72.03%-3.15M-214.27%-727.71K-115.28%-689.36K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K
Investing cash flow
Cash flow from continuing investing activities -104.80%-14.43K0200.00%300.55K0
Net PPE purchase and sale ---------------14.43K--0--------------0----
Net investment purchase and sale --------------0----------------200.00%300.55K--0
Cash from discontinued investing activities
Investing cash flow -------------104.80%-14.43K--0------------200.00%300.55K--0
Financing cash flow
Cash flow from continuing financing activities 820.33K0900.00%200K-74.49%1.34M-69.24%1.61M0-250K-25K149.82%5.24M233,138.20%5.24M
Net issuance payments of debt --0--0--0-200.00%-275K--0--0---250K---25K--275K--275K
Net common stock issuance --820.33K--0--200K--0--0--0--0--0136.71%4.96M----
Proceeds from stock option exercised by employees --------------1.61M------------------0----
Cash from discontinued financing activities
Financing cash flow --820.33K--0900.00%200K-74.49%1.34M-69.24%1.61M--0---250K---25K149.82%5.24M233,138.20%5.24M
Net cash flow
Beginning cash position -61.89%1.19M-47.61%2.11M-35.69%3.29M262.26%5.12M1,999.68%2.41M615.81%3.11M869.77%4.02M262.26%5.12M133.02%1.41M-94.74%114.77K
Current changes in cash 123.76%167.23K-1.51%-918.79K-7.75%-1.19M-149.30%-1.83M-82.35%883.89K-119.79%-703.8K-4,497.79%-905.11K-10.36%-1.1M359.42%3.71M750.70%5.01M
End cash Position -43.82%1.35M-61.89%1.19M-47.61%2.11M-35.69%3.29M-35.69%3.29M1,999.68%2.41M615.81%3.11M869.77%4.02M262.26%5.12M262.26%5.12M
Free cash flow 7.20%-653.1K-40.25%-918.79K-28.80%-1.39M-72.82%-3.16M-214.27%-727.71K-119.79%-703.8K-12.96%-655.11K-54.12%-1.08M-85.10%-1.83M50.85%-231.56K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data